Publication:
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season

Simple item page
dc.contributor.authorRondy, Marc
dc.contributor.authorGherasim, Alin Manuel
dc.contributor.authorCasado, Itziar
dc.contributor.authorLaunay, Odile
dc.contributor.authorRizzo, Caterina
dc.contributor.authorPitigoi, Daniela
dc.contributor.authorMickiene, Aukse
dc.contributor.authorMarbus, Sierk D
dc.contributor.authorMachado, Ausenda
dc.contributor.authorSyrjänen, Ritva K
dc.contributor.authorPem-Novose, Iva
dc.contributor.authorHorváth, Judit Krisztina
dc.contributor.authorLarrauri, Amparo
dc.contributor.authorCastilla, Jesús
dc.contributor.authorVanhems, Philippe
dc.contributor.authorAlfonsi, Valeria
dc.contributor.authorIvanciuc, Alina E
dc.contributor.authorKuliešė, Monika
dc.contributor.authorvan Gageldonk-Lafeber, Rianne
dc.contributor.authorGomez, Verónica
dc.contributor.authorIkonen, Niina
dc.contributor.authorLovric, Zvjezdana
dc.contributor.authorFerenczi, Annamária
dc.contributor.authorI-MOVE+ hospital working group
dc.contributor.authorMoren, Alain
dc.contributor.funderUnión Europea
dc.date.accessioned2020-01-30T09:33:07Z
dc.date.available2020-01-30T09:33:07Z
dc.date.issued2017
dc.description.abstractIn a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A(H3N2) in 2016/17. Adjusted IVE was 17% (95% confidence interval (CI): 1 to 31) overall; 25% (95% CI: 2 to 43) among 65-79-year-olds and 13% (95% CI: -15 to 30) among those ≥ 80 years. As the A(H3N2) vaccine component has not changed for 2017/18, physicians and public health experts should be aware that IVE could be low where A(H3N2) viruses predominate.es_ES
dc.description.peerreviewedSíes_ES
dc.description.sponsorshipThe I-MOVE+ project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634446. The Lithuanian I-MOVE+ study sites were supported by a grant from the Research Council of Lithuania (SEN-03/2015). We are grateful to all patients, medical staff, study nurses and epidemiologists from the 12 study sites who actively participated in the study.oin.es_ES
dc.format.number41es_ES
dc.format.volume22es_ES
dc.identifier.citationEuro Surveill. 2017 Oct;22(41).es_ES
dc.identifier.doi10.2807/1560-7917.ES.2017.22.41.17-00645es_ES
dc.identifier.e-issn1560-7917es_ES
dc.identifier.issn1560-7917es_ES
dc.identifier.journalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletines_ES
dc.identifier.pubmedID29043961es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/8994
dc.language.isoenges_ES
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC)
dc.relation.projectIDEuropean Union’s Horizon 2020 research and innovation programme under grant agreement No 634446es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SEN-03/2015es_ES
dc.relation.publisherversionhttps://doi.org/10.2807/1560-7917.ES.2017.22.41.17-00645es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectA(H3N2)es_ES
dc.subjectInfluenzaes_ES
dc.subjectCases controles_ES
dc.subjectElderlyes_ES
dc.subjectHospitalisationes_ES
dc.subjectVaccine effectivenesses_ES
dc.subject.meshAdolescentes_ES
dc.subject.meshAdultes_ES
dc.subject.meshAgedes_ES
dc.subject.meshEuropean Uniones_ES
dc.subject.meshFemalees_ES
dc.subject.meshHospitalizationes_ES
dc.subject.meshHospitalses_ES
dc.subject.meshHumanses_ES
dc.subject.meshInfluenza A Virus, H3N2 Subtypees_ES
dc.subject.meshInfluenza Vaccineses_ES
dc.subject.meshInfluenza, Humanes_ES
dc.subject.meshMalees_ES
dc.subject.meshMiddle Agedes_ES
dc.subject.meshOutcome Assessment, Health Carees_ES
dc.subject.meshSeasonses_ES
dc.titleLow 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 seasones_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicatione264f82c-6c07-4aa5-9f71-45e555f6592b
relation.isAuthorOfPublicatione77e1f2d-b4e2-4ba5-a853-c2795850dcae
relation.isAuthorOfPublication7ac13a7f-3d30-4846-8b51-b7505c7df45c
relation.isAuthorOfPublication.latestForDiscoverye264f82c-6c07-4aa5-9f71-45e555f6592b
relation.isFunderOfPublicationb029ca7c-43c2-46be-af9e-b34b7f455d94
relation.isFunderOfPublication.latestForDiscoveryb029ca7c-43c2-46be-af9e-b34b7f455d94
relation.isPublisherOfPublication844b1441-479c-4219-87e5-efc493160a02
relation.isPublisherOfPublication.latestForDiscovery844b1441-479c-4219-87e5-efc493160a02

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Low2016_17SeasonVaccine_2017.pdf
Size:
125.81 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Centro Nacional de Epidemiología (CNE)
IdiSNA - Instituto de Investigación Sanitaria de Navarra (Navarra)